NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

市场调查报告书

羟考酮医药品市场:2019-2025年

Oxycodone Drug Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品编码 949574
出版日期 内容资讯 英文
商品交期: 2-3个工作天内
价格
羟考酮医药品市场:2019-2025年 Oxycodone Drug Market 2019-2025
出版日期: 2020年06月12日内容资讯: 英文
简介

预计全球羟考酮药物市场在预测期内将显著增长。癌症和艾滋病毒等晚期疾病的发病率增加,处方止痛药的激增,正在推动全球羟考酮药物市场的增长。新药的开发为羟考酮市场提供了巨大的机会。Oxycontin和Opana的抗滥用配方等将革新药物配方和药物设计的新产品将振兴品牌的镇静剂市场。此外,美国食品和药物管理局(FDA)敦促制药公司提出不易上瘾的新一代药物。

本报告提供全球羟考酮医药品市场相关调查分析,提供市场概要,市场成长的影响要素,市场规模与预测,各市场区隔的市场分析,各地各国的市场分析,竞争情形等相关的系统性资讯。

目录

第1章 报告概要

第2章 市场概要及考察

  • 调查范围
  • 分析师的考察&目前市场趋势

第3章 竞争情形

  • 企业占有率分析
  • 主要策略分析
  • 主要企业分析
    • Purdue Pharma L.P
    • Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Subsidiary)
    • Hikma Pharmaceuticals USA, Inc.
    • Pfizer, Inc.
    • Sanofi-Aventis S.A.

第4章 市场决策要素

  • 促进因素
  • 阻碍因素
  • 机会

第5章 市场区隔

  • 全球羟考酮医药品市场:各用途
    • 疼痛管理
    • 麻醉
    • 中毒管理

第6章 地区分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 其他亚太地区
  • 其他地区

第7章 企业简介

  • Allergan PLC
  • Endo Pharmaceuticals, Inc.
  • Grunenthal GmbH
  • Hikma Pharmaceuticals USA, Inc.
  • Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Subsidiary)
  • Pfizer, Inc.
  • Purdue Pharma L.P
  • Sanofi-Aventis S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vistapharm Inc.
目录
Product Code: OMR2021893

Global Oxycodone Drug Market Size, Share & Trends Analysis Report, by Applications (Pain Management, Anesthesia, and Addiction Management), and Forecast Period 2019-2025

The global oxycodone drug market is estimated to grow at a significant CAGR during the forecast period. The increasing frequency of terminally ill diseases such as cancer and HIV and a high surge in post-operative pain prescribed medication is driving the growth of the global oxycodone drug market.New drug development is a large market opportunity for the oxycodone market. New products with innovations in formulations and drug designing such as abuse-deterrent formulations done in Oxycontin and Opana, fuel the branded opiate market. Moreover, the US Food and Drug Administration is also encouraging drug makers to come up with a new generation drug that is less addictive.

An increase in new drug applications by pharmaceutical companies and the number of products in the pipeline drives the future opportunity growth of the global oxycodone market. Other formulations such as control release of drugs for improved pain management are coming up in the market. Advanced drug formulations such as extended-release medications for pain control are examples of improved formulation driving the market.

The global oxycodone market is segmented into applications into pain management, anesthesia, and de-addiction. Pain management accounts for the largest market portion, owing to the increasing frequency of Parkinson's syndrome, rheumatic, and cancer patients. Geographically, theglobal oxycodone drugs market is segmented based on the region including North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

The major manufactures of the oxycodone drug include Purdue Pharma L.P, Janssen Pharmaceuticals (A Johnson & Johnson Subsidiary), Inc., Hikma Pharmaceuticals USA, Inc., Pfizer, Inc., Sanofi-Aventis S.A., Sun Pharmaceutical Industries Ltd., and others. The range of oxycodone drugs provided by these companies is Oxynorm, OxyContin, Endone, Proladone, Targin, and more. These companies are receiving approvals for new drugs that are expected to contribute to the oxycodone drug market. For instance, in April 2017, the FDA approved RoxyBond, a new formulation of immediate-release oxycodone. This oxycodone formulation is the first immediate-release opioid analgesic approved with labeling describing its abuse-deterrent properties.

Research Methodology

The market study of the global oxycodone drugs market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Reports of companies involved in the market
  • Authentic Public Databases
  • Whitepapers such as research papers and news blogs
  • Company websites and their product catalog

The report is intended for providers, suppliers, and distributors of fiberglass, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and will serve as a source for 360-degree analysis of the market.

Market Segmentation-

  • Global Oxycodone Drugs Market by Type
  • Global Oxycodone Drugs Market by Application

The Report Covers:

  • Comprehensive research methodology of the global oxycodone drug market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Insights about market determinants which are stimulating the global oxycodone drugs market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusions

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Purdue Pharma L.P
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Subsidiary)
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Hikma Pharmaceuticals USA, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Pfizer, Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Sanofi-Aventis S.A.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Oxycodone Drug Market byApplication
    • 5.1.1. Pain Management
    • 5.1.2. Anesthesia
    • 5.1.3. Addiction Management

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Allergan PLC
  • 7.2. Endo Pharmaceuticals, Inc.
  • 7.3. Grunenthal GmbH
  • 7.4. Hikma Pharmaceuticals USA, Inc.
  • 7.5. Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Subsidiary)
  • 7.6. Pfizer, Inc.
  • 7.7. Purdue Pharma L.P
  • 7.8. Sanofi-Aventis S.A.
  • 7.9. Sun Pharmaceutical Industries Ltd.
  • 7.10. Teva Pharmaceutical Industries Ltd.
  • 7.11. Vistapharm Inc.

LIST OF TABLES

  • 1. GLOBAL OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 2. GLOBAL OXYCODONE DRUG FOR PAIN MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL OXYCODONE DRUG FOR ANESTHESIA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL OXYCODONE DRUG FOR ADDICTION MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBALOXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 7. NORTH AMERICAN OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 8. NORTH AMERICAN OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 9. EUROPEAN OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 10. EUROPEAN OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 11. ASIA-PACIFIC OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 12. ASIA-PACIFIC OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 13. REST OF THE WORLD OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL OXYCODONE DRUG MARKET SHARE BY TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL OXYCODONE DRUG MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
  • 3. GLOBAL OXYCODONE DRUG MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)